THE PERTHERA REPORT 

The Perthera Report provides precisely matched therapeutic options ranked for the highest probability of best outcome.

THE PERTHERA REPORT PROVIDES SIGNIFICANTLY MORE THERAPEUTIC OPTIONS. 

In 73% of patients, the Perthera Report provided more therapeutic options than were provided by testing labs; 75% of these additional therapeutic options were clinical trials. Use of the Perthera Report provides two benefits: (1) More scientifically and biologically reasoned and ranked treatment options to help oncologists improve results for their patients and (2) identify clinical trials to bring to your hospital to increase clinical trial revenue opportunity.

1 Manuscript for publication in draft
2 Perthera pancreatic cancer patients compared to NAPOLI-1 Study (76 Sites, 14 Countries, 417 Patients)
3 For patients who have begun a new therapy based on the Perthera Report after receiving the Perthera Report
4 Manuscript for publication in draft 5 For patients who have begun a new therapy based on the Perthera Report after receiving the Perthera Report